Slides
Page 1
1 Jupiter Life Line Hospitals Limited Results Presentation – Q2 & H1FY26
Page 2
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Jupiter Life Line Hospitals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. This presentation contains certain forward looking statements concerning the Company’s future business prospects and business profitability, which are subject to a number of risks and uncertainties and the actual results could materially differ from those in such forward looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, competition (both domestic and international), economic growth in India and abroad, ability to attract and retain highly skilled professionals, time and cost over runs on contracts, our ability to manage our international operations, government policies and actions regulations, interest and other fiscal costs generally prevailing in the economy. The Company does not undertake to make any announcement in case any of these forward looking statements become materially incorrect in future or update any forward looking statements made from time to time by or on behalf of the Company. 2
Page 3
Management Commentary 3 Dr. Ankit Thakker JMD & CEO P a t i e n t F i r s t “It has been an uneventful quarter, with all our existing hospitals performing as per expectations. As outlined earlier, Pune is nearing maturity, and the Indore hospital is showing improved growth following the brownfield expansion that was undertaken earlier this year. The Dombivli Hospital project is progressing on schedule. From this quarter, we have moved towards the interiors, services and finishing stages of the hospital and will begin with team building soon. As committed last quarter, we have begun with the construction work for our South Pune facility from Q3FY26. We hope to commence operations of this facility in CY28. We continue to leverage our operational strengths, clinical excellence and patient-centric approach to drive sustainable growth and reinforce our leadership position in Western India’s healthcare sector.”
Page 4
Q2FY26 Performance Highlights 51.7 57.4 Q2FY25 Q2FY26 +11.0% 58.4 67.0 261.6 290.6 15.0 Q2FY25 16.8 Q2FY26 335.1 374.4 +11.7% IPD OPD Others 70.0 74.2 Q2FY25 Q2FY26 +6.1% 78.1 85.4 Q2FY25 Q2FY26 +9.3% Rs in Cr 4 Total Income* EBITDA* PBT PAT *This is the Operational Income and EBITDA. Unbilled revenue and Doctors’ provision are excluded
Page 5
H1FY26 Performance Highlights 96.3 101.4 H1FY25 H1FY26 +5.3% 113.0 130.1 491.5 565.4 28.4 H1FY25 31.9 H1FY26 632.9 727.4 +14.9% IPD OPD Others 130.6 136.0 H1FY25 H1FY26 +4.1% 144.1 163.8 H1FY25 H1FY26 +13.7% Rs in Cr 5 Total Income* EBITDA* PBT PAT *This is the Operational Income and EBITDA. Unbilled revenue and Doctors’ provision are excluded
Page 6
H1FY26 Operating Metrics 132 132 851 929 H1FY25 H1FY26 983 1,061 68.5% 62.2% H1FY25 H1FY26 57,700 66,100 H1FY25 H1FY26* 3.85 3.84 H1FY25 H1FY26 458.8 511.5 27.2 H1FY25 27.4 H1FY26 IPD OPD 486.0 538.9 55.4% 55.5% 43.2% 1.1% 43.5% H1FY25 1.3% H1FY26 Government Schemes Self Payors Insurance Companies Census Beds Non - Census Beds 6 ARPOB rounded off to the nearest hundred Operational Bed Capacity(1) Average Occupancy Rate(2) IPD & OPD Volumes (‘000)(3) ARPOB(4) ALOS (in Days)(5) Payor Mix 1) Operational beds includes census beds (bed available for mid-night occupancy such as intensive care units (“ICUs”), wards etc.) and non-census beds (all other bed available other than census beds, such as day-care beds, casualty beds etc.) (2) Average occupancy rate is calculated as census occupied bed days (i.e. midnight census of occupied census beds during the period) divided by available census bed days (i.e. census bed capacity multiplied by the applicable days in the relevant period) (3) Out-patient volume refers to the total number of Out-patient bills generated in a specific period. Inpatient volume refers to the total number of inpatient discharge in a specific period irrespective of admission date. (4) ARPOB is calculated as income from hospital services divided by census occupied bed days (i.e. midnight census of occupied census beds during the period) (5) ALOS is the average length of stay of patients in a specific period, calculated as census occupied bed days (i.e. midnight census of occupied census beds during the period) divided by inpatient volume. *This is the Operational Income and EBITDA. Unbilled revenue and Doctors’ provision are excluded H1FY26 Occupancy reflects occupancy of the expanded bed capacity
Page 7
Profit and Loss (in Rs. Crs) Q2FY26 Q2FY25 YoY Q1FY26 QoQ H1FY26 H1FY25 YoY FY25 Revenue from Operations 376.8* 320.0 11.7% 337.9 5.8% 714.7* 604.5 15.1% 1,245.4 Other Income - Operational 16.8 15.0 15.1 31.9 28.4 57.0 Total Income 393.6 335.1 17.5% 353.0 11.5% 746.6 632.9 18.0% 1,302.4 Cost of Goods Sold 73.8 66.0 70.7 144.5 122.2 255.5 Gross Profit 319.9 269.1 18.9% 282.2 13.3% 602.1 510.7 17.9% 1,046.9 Gross Profit Margin 81.3% 80.3% 80.0% 80.6% 80.7% 80.4% Employee Cost 63.2 56.2 61.7 125.0 109.6 225.2 Professional Fees 103.0# 78.3 82.7 185.7# 148.4 305.3 Other Expenses 61.4 56.5 59.4 120.8 108.7 216.3 EBITDA 92.2 78.1 18.1% 78.4 17.6% 170.7 144.1 18.5% 300.1 EBITDA Margin 23.4% 23.3% 22.2% 22.9% 22.8% 23.0% Depreciation 21.5 14.4 21.2 42.7 25.4 57.1 EBIT 70.8 63.7 11.1% 57.2 23.7% 128.0 118.6 7.9% 243.0 EBIT Margin 18.0% 19.0% 16.2% 17.1% 18.7% 18.7% Other Income - Finance 11.3 7.4 12.8 24.1 14.3 28.3 Finance Cost 7.8 1.2 8.3 16.1 2.3 10.7 PBT 74.2 70.0 6.1% 61.7 20.2% 136.0 130.6 4.1% 260.7 PBT Margin 18.9% 20.9% 17.5% 18.2% 20.6% 20.0% Tax 16.8 18.2 17.8 34.6 34.4 66.9 PAT 57.4 51.7 11.0% 43.9 30.7% 101.4 96.3 5.3% 193.8 PAT Margin 14.6% 15.4% 12.5% 13.6% 15.2% 14.9% Basic EPS 8.75 7.88 6.69 15.44 14.63 29.47 Consolidated Profit & Loss Statement 7*Operational revenue includes unbilled revenue of Rs 19.2 cr #Professional Fees include additional provision of Rs 12.3 cr towards unsettled outstanding receivables
Page 8
Consolidated Balance Sheet 8 Equity & Liabilities (in Rs. Crs) Sep-25 Mar-25 Assets (in Rs. Crs) Sep-25 Mar-25 Total Equity 1,450.9 1,356.3 Non - Current Assets 1,332.7 1,217.9 Share Capital 65.6 65.6 Property Plant & Equipments 892.8 899.4 Other Equity 1,385.4 1,290.6 Right of use assets 100.5 74.0 Non-Controlling interest 0.0 0.1 CWIP 296.4 185.1 Non-Current Liabilities 398.2 395.8 Other Intangible assets 4.2 4.6 Financial Liabilities Financial Assets Borrowings 318.9 321.7 Investments 0.1 0.1 Lease liabilities 70.4 62.3 Other Financial Assets 32.2 53.5 Provisions 5.9 4.7 Other Non - Current Assets (Net) 6.5 1.2 Deferred Tax Liabilities 3.0 7.1 Current Assets 690.1 692.5 Current Liabilities 173.7 158.4 Inventories 27.6 26.5 Financial Liabilities Financial Assets Borrowings 4.5 4.0 Investments 526.2 509.8 Lease liabilities 9.7 5.1 Trade receivables 75.7 43.2 Trade Payables 52.4 69.1 Cash and cash equivalents 26.2 92.5 Other financial Liabilities 69.9 51.3 Bank balances other than above 3.4 2.5 Other Current Liabilities 23.9 23.4 Other financial assets 7.9 - Current tax liabilities (net) 11.4 3.5 Current tax assets (net) 9.3 6.2 Provisions 1.9 2.0 Other Current Assets 13.8 11.9 Total Equity & Liabilities 2,022.8 1,910.5 Total Assets 2,022.8 1,910.5
Page 9
Consolidated Cash Flow Statement 9 Profit and Loss (in Rs. Crs) H1FY26 H1FY25 Net Profit Before Tax 136.0 130.6 Adjustments for: Non -Cash Items / Other Investment or Financial Items 41.6 23.2 Operating profit before working capital changes 177.6 153.8 Changes in working capital -13.7 2.5 Cash generated from Operations 163.9 156.3 Direct taxes paid (net of refund) -33.8 -32.9 Net Cash from Operating Activities 130.1 123.4 Net Cash from Investing Activities -173.2 -122.8 Net Cash from Financing Activities -23.2 -8.3 Net Decrease in Cash and Cash equivalents -66.3 -7.7 Add: Cash & Cash equivalents at the beginning of the period 92.5 26.4 Cash & Cash equivalents at the end of the period 26.2 18.7
Page 10
Scaling up for better care: Setting up New hospitals 10 Location Expected Bed Addition Phase I Expected Bed Addition Phase II Total Bed Capacity Capex Estimated (Rs in cr) Expected to Operationalise Current Status of Phase I Dombivli 200-220 280-300 500 500 Q1FY27 Project is on track Pune South (Bibwewadi) 200-220 280-300 500 500 CY28 Construction has begun in Q3FY26 Mira - Bhayandar 150-170 130-150 300 400 CY29 On the drawing board Upcoming Hospitals Total Existing Beds 1,061 Addition of Beds ~1,440* Total Beds Capacity ~2,500 *Includes additional beds at existing hospitals
Page 11
Thank You Jupiter Life Line Hospitals Limited CIN: L85100MH2002PLC137908 investor.relations@jupiterhospital.com Strategic Growth Advisors Pvt. Ltd. http://www.sgapl.net/images/sgapl_logo.jpg CIN: U74140MH2010PTC204285 Mandar Chavan / Rahul Agarwal mandar.chavan@sgapl.net / rahul.agarwal@sgapl.net +91 96993 82195 / +91 98214 38864 Jupiter Life Line Hospitals Limited CIN: L85100MH2002PLC137908 investor.relations@jupiterhospital.com